Merck Property, Plant, and Equipment 2010-2024 | MKKGY
Merck property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Merck property, plant, and equipment for the quarter ending June 30, 2024 was $10.158B, a 11% increase year-over-year.
- Merck property, plant, and equipment for 2023 was $9.801B, a 13.41% increase from 2022.
- Merck property, plant, and equipment for 2022 was $8.643B, a 1.22% increase from 2021.
- Merck property, plant, and equipment for 2021 was $8.538B, a 16.41% increase from 2020.
Merck Annual Property, Plant, and Equipment
(Millions of US $) |
| 2023 |
$9,801 |
| 2022 |
$8,643 |
| 2021 |
$8,538 |
| 2020 |
$7,335 |
| 2019 |
$6,959 |
| 2018 |
$5,682 |
| 2017 |
$5,100 |
| 2016 |
$4,681 |
| 2015 |
$4,449 |
| 2014 |
$3,975 |
| 2013 |
$3,516 |
| 2012 |
$3,799 |
| 2011 |
$4,337 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Property, Plant, and Equipment
(Millions of US $) |
| 2024-06-30 |
$10,158 |
| 2024-03-31 |
$10,004 |
| 2023-12-31 |
$9,801 |
| 2023-09-30 |
$9,490 |
| 2023-06-30 |
$9,152 |
| 2023-03-31 |
$8,821 |
| 2022-12-31 |
$8,643 |
| 2022-09-30 |
$8,003 |
| 2022-06-30 |
$8,059 |
| 2022-03-31 |
$8,195 |
| 2021-12-31 |
$8,538 |
| 2021-09-30 |
$7,973 |
| 2021-06-30 |
$7,954 |
| 2021-03-31 |
$7,899 |
| 2020-12-31 |
$7,335 |
| 2020-09-30 |
$7,046 |
| 2020-06-30 |
$6,680 |
| 2020-03-31 |
$6,741 |
| 2019-12-31 |
$6,959 |
| 2019-09-30 |
$5,978 |
| 2019-06-30 |
$5,902 |
| 2019-03-31 |
$6,010 |
| 2018-12-31 |
$5,682 |
| 2018-09-30 |
$5,289 |
| 2018-06-30 |
$5,346 |
| 2018-03-31 |
$5,492 |
| 2017-12-31 |
$5,100 |
| 2017-09-30 |
$4,986 |
| 2017-06-30 |
$4,632 |
| 2017-03-31 |
$4,495 |
| 2016-12-31 |
$4,681 |
| 2016-09-30 |
$4,483 |
| 2016-06-30 |
$4,495 |
| 2016-03-31 |
$4,354 |
| 2015-12-31 |
$9,818 |
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
